The predominant adverse reactions are gastrointestinal, affecting about 50% of users, and can include stomach discomfort, nausea, and a metallic taste in the mouth
What you eat also matters
Manejo de Efectos Secundarios Para minimizar estos efectos secundarios, se recomienda comenzar con una dosis baja de L-carnitina y aumentarla gradualmente
Holst emphasizes the potential for GLP-1 therapies to address neurological conditions in addition to metabolic diseases, broadening their application and impact
Lifestyle instructions should reinforce treatment goals
A notable obstacle is regulatory challenges, since the intricacy of liposomal formulations creates ambiguities in characterisation, quality assurance, and long-term stability, so rendering regulatory approval processes more rigorous